UroGen Pharma Ltd. Inventory, Raw Materials, Gross
UroGen Pharma Ltd. (URGN) had Inventory, Raw Materials, Gross of $2.89 million as of 2021-06-30, per its 10-Q filed 2021-08-04.
Discontinued › Notes
us-gaap:InventoryRawMaterials · last filed 2021-08-04
- 2021-06-30: Inventory, Raw Materials, Gross $2.89M.
- 2021-03-31: Inventory, Raw Materials, Gross $2.44M.
- 2020-12-31: Inventory, Raw Materials, Gross $1.05M.
- 2020-09-30: Inventory, Raw Materials, Gross $927.00K.
| Period end | Inventory, Raw Materials, Gross |
|---|---|
| 2021-06-30 | $2.89M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $2.44M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $1.05M 10-Q · filed 2021-08-04 |
| 2020-09-30 | $927.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $893.00K 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |